Galmed Pharmaceuticals Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$3.63

+0.13 (+3.57%)

As of Sep 28, 10:47 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +375.9% upside

Low Target $9.83

Average Target $17.25

High Target $23.67

Current Price $3.63

Current
$3.63

Target
$17.25

$9.83 $17.25 avg $23.67

Scenario Analysis

Bear Case

$9.83

171.2%

Low target

Base Case

$17.25

+375.9%

Avg target

Bull Case

$23.67

+553.0%

High target

Risk/Reward

3.2x

Highly favorable

Price in Context

52-Week High

$13.20

-72.5% from high

52-Week Low

$3.27

+11.0% from low

Target vs 52W High

$17.25

+30.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%